KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Enterprise Value (2016 - 2025)

Globus Medical's Enterprise Value history spans 15 years, with the latest figure at -$557.2 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 37.39% year-over-year to -$557.2 million; the TTM value through Dec 2025 reached -$557.2 million, up 37.39%, while the annual FY2025 figure was -$557.2 million, 37.39% up from the prior year.
  • Enterprise Value reached -$557.2 million in Q4 2025 per GMED's latest filing, down from -$390.5 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$229.4 million in Q2 2025 to a low of -$890.1 million in Q4 2024.
  • Average Enterprise Value over 5 years is -$492.4 million, with a median of -$465.1 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: plummeted 71.9% in 2024, then surged 53.45% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$443.4 million in 2021, then fell by 0.59% to -$446.1 million in 2022, then dropped by 16.08% to -$517.8 million in 2023, then tumbled by 71.9% to -$890.1 million in 2024, then skyrocketed by 37.39% to -$557.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Enterprise Value are -$557.2 million (Q4 2025), -$390.5 million (Q3 2025), and -$229.4 million (Q2 2025).